Plain-English translation of NCT06702696 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether aronia melanocarpa (a dark purple berry also called black chokeberry) can help reduce inflammation in people with COPD, a chronic lung disease that makes breathing difficult. Researchers will ask half the participants to consume 30 grams of freeze-dried aronia powder daily for a set period, while the other half will receive a placebo powder that looks and tastes the same. The study will measure whether the medication reduces inflammatory markers in the blood.
COPD causes the airways to become inflamed and damaged, making it harder to breathe. Current treatments help manage symptoms, but researchers are looking for additional ways to reduce inflammation and improve quality of life for people living with this disease.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either eat 30 grams of freeze-dried aronia powder daily or a placebo powder that looks identical. The study will run from November 2024 to November 2025, and you will visit the pulmonology clinic at Yedikule Hospital for check-ups where researchers will measure inflammation markers in your blood and assess your lung function. You will need to commit to consuming the powder regularly and attending all study visits.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Turkey (Türkiye)